Logo image of ONMD

ONEMEDNET CORP (ONMD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ONMD - US68270C1036 - Common Stock

1.13 USD
-0.06 (-5.04%)
Last: 1/9/2026, 8:15:04 PM
1.15 USD
+0.02 (+1.77%)
After Hours: 1/9/2026, 8:15:04 PM
Fundamental Rating

0

ONMD gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. ONMD may be in some trouble as it scores bad on both profitability and health. ONMD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ONMD had negative earnings in the past year.
In the past year ONMD has reported a negative cash flow from operations.
In the past 5 years ONMD always reported negative net income.
ONMD had negative operating cash flow in 4 of the past 5 years.
ONMD Yearly Net Income VS EBIT VS OCF VS FCFONMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

With a Return On Assets value of -150.07%, ONMD is not doing good in the industry: 91.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -150.07%
ROE N/A
ROIC N/A
ROA(3y)-1920.19%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONMD Yearly ROA, ROE, ROICONMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ONMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONMD Yearly Profit, Operating, Gross MarginsONMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

0

2. Health

2.1 Basic Checks

ONMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ONMD has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ONMD has an improved debt to assets ratio.
ONMD Yearly Shares OutstandingONMD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
ONMD Yearly Total Debt VS Total AssetsONMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -110.06, we must say that ONMD is in the distress zone and has some risk of bankruptcy.
ONMD has a worse Altman-Z score (-110.06) than 97.14% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -110.06
ROIC/WACCN/A
WACC8.77%
ONMD Yearly LT Debt VS Equity VS FCFONMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

A Current Ratio of 0.29 indicates that ONMD may have some problems paying its short term obligations.
ONMD has a worse Current ratio (0.29) than 91.43% of its industry peers.
A Quick Ratio of 0.29 indicates that ONMD may have some problems paying its short term obligations.
ONMD has a Quick ratio of 0.29. This is amonst the worse of the industry: ONMD underperforms 91.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
ONMD Yearly Current Assets VS Current LiabilitesONMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 93.45% over the past year.
Looking at the last year, ONMD shows a very negative growth in Revenue. The Revenue has decreased by -69.79% in the last year.
The Revenue for ONMD have been decreasing by -16.18% on average. This is quite bad
EPS 1Y (TTM)93.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.89%
Revenue 1Y (TTM)-69.79%
Revenue growth 3Y-16.18%
Revenue growth 5YN/A
Sales Q2Q%24.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ONMD Yearly Revenue VS EstimatesONMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ONMD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONMD Price Earnings VS Forward Price EarningsONMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONMD Per share dataONMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ONMD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ONEMEDNET CORP

NASDAQ:ONMD (1/9/2026, 8:15:04 PM)

After market: 1.15 +0.02 (+1.77%)

1.13

-0.06 (-5.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners23.51%
Inst Owner Change0%
Ins Owners58.25%
Ins Owner Change7.18%
Market Cap57.64M
Revenue(TTM)495.00K
Net Income(TTM)-2.26M
AnalystsN/A
Price TargetN/A
Short Float %2.9%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 116.45
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.01
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -150.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1920.19%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3101.22%
Cap/Sales 513.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -110.06
F-Score3
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)1855.97%
Cap/Depr(5y)N/A
Cap/Sales(3y)156.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-69.79%
Revenue growth 3Y-16.18%
Revenue growth 5YN/A
Sales Q2Q%24.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-112.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.18%
OCF growth 3YN/A
OCF growth 5YN/A

ONEMEDNET CORP / ONMD FAQ

What is the ChartMill fundamental rating of ONEMEDNET CORP (ONMD) stock?

ChartMill assigns a fundamental rating of 0 / 10 to ONMD.


What is the valuation status of ONEMEDNET CORP (ONMD) stock?

ChartMill assigns a valuation rating of 0 / 10 to ONEMEDNET CORP (ONMD). This can be considered as Overvalued.


What is the profitability of ONMD stock?

ONEMEDNET CORP (ONMD) has a profitability rating of 0 / 10.